# High-salt diet induces immune-independent re-differentiation, metabolic shut down and cell cycle arrest of melanoma

**Authors:** Clivia Lisowski, Natascha E. Stumpf, Katarzyna Jobin, Daniela Klaus, Melanie Eichler, Ann-Kathrin Baumgart, Olena Babyak, Mirjam Meißner, Agnes Schröder, Patrick Neubert, Vanessa Schmitt, Marcel Michla, Süleyman Bozkurt, Jelena Zurkovic, Daniel Hinze, Jana Liebing, Matthias Eckhardt, Christoph Heuser, Lea Seep, Annkristin Heine, Janine Becker-Gotot, Christoph Thiele, Christian Münch, Thomas Becker, Jonathan Jantsch, Christoph Wilhelm, Michael Hölzel, Christian Kurts

PMC · DOI: 10.1038/s41419-025-08329-x · Cell Death & Disease · 2025-12-20

## TL;DR

A high-salt diet stops melanoma growth by making cancer cells behave more like normal cells, without needing immune help.

## Contribution

The study reveals a new mechanism where high salt diet causes melanoma re-differentiation and metabolic shutdown, independent of immune cells.

## Key findings

- High-salt diet upregulates TSC2, causing metabolic shutdown in melanoma cells.
- MITF upregulation leads to melanogenesis and cell cycle arrest in melanoma cells.
- Melanoma cells re-differentiate into a normal melanocytic state under high-salt conditions.

## Abstract

High salt diet (HSD) is known to reduce cancer growth in some tumor models, which has been attributed to tissue accumulation of sodium that enhances local anti-tumor immunity. Here, we show that a HSD inhibits melanoma growth independent of sodium accumulation and immune cells in skin and lung. Melanoma cells from mice on a HSD upregulated the metabolic inhibitor Tuberous sclerosis complex 2 (TSC2), causing metabolic shutdown despite nutrient availability. Furthermore, Microphthalmia-associated transcription factor (MITF), a crucial regulator of melanoma metabolism and differentiation, was upregulated, resulting in enhanced melanogenesis and cell cycle arrest. Thus, a HSD reversed the de-differentiation of melanoma cells and promoted their re-differentiation into a “normal” melanocytic state. These findings suggest that the anti-tumor effect of HSD may be tumor-specific and in some cases immune cell-independent.

## Linked entities

- **Genes:** TSC2 (TSC complex subunit 2) [NCBI Gene 7249], MITF (melanocyte inducing transcription factor) [NCBI Gene 4286]
- **Diseases:** melanoma (MONDO:0005105)

## Full-text entities

- **Genes:** Tsc2 (TSC complex subunit 2) [NCBI Gene 22084] {aka Nafld, Tcs2}, Mitf (melanogenesis associated transcription factor) [NCBI Gene 17342] {aka BCC2, Bhlhe32, Gsfbcc2, Vitiligo, Wh, bw}
- **Diseases:** cancer (MESH:D009369), Melanoma (MESH:D008545)
- **Chemicals:** salt (MESH:D012492), sodium (MESH:D012964)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12847697/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12847697/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12847697/full.md

---
Source: https://tomesphere.com/paper/PMC12847697